47. Yang B, Li B, Zhu Y, Zhao M, Cheng Y, Zhao X, Deryn Teoh E, Zhang M, Tang X, Zhang X, Xue B, Yan J, Lin Z, Luo M, Yu H, Zhang L*, Chen X*, Ni Q*. In Submission.

​

46. Zhang M, Wang Y, Li B, Yang B, Zhao M, Li B, Liu J, Hu Y, Wu Z, Ong Y, Han X, Ding L, Zhu K, Li J, Luo M, Chen S, Peng L, Zhang L*, Chen X*, Ni Q*, STING‐Activating Polymers Boost Lymphatic Delivery of mRNA Vaccine to Potentiate Cancer Immunotherapy. Adv. Mater. 2024, 2412654.  https://doi.org/10.1002/adma.202412654 

​

45. Cao B, Ni Q, Chen Z, Yang S, Zhang X, Su H, Zhang Z, Zhao Q, Zhu X, Liu M. Development of GPC3-CAR-NK cells and optimization as a therapy for HCC. Journal of Leukocyte Biology. 2024. Jun 26:qiae144.

​​

44. Li B, Zhao M, Lai W, Zhang X, Yang B, Chen X, Ni Q*. Activatable NIR-II photothermal lipid nanoparticles for improved messenger RNA delivery. Angew Chem Int Engl. 2023. 62(25): e202302676.

​​​

43. Wang K, Zhang X, Ye H, Wang X, Fan Z, Lu Q, Li S, Zhao J, Zheng S, He Z, Ni Q*, et al. Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy. Nat Commun. 2023. 14(1): 6748.

​​​

42. Ong YH, Zheng W, Khong PL, Ni Q*. Application of radiogenomics in head and neck cancer: A new tool toward diagnosis and therapy. iRadiology. 2024, 1-15.

​​​

41. Zhang X, Yang B, Ni Q*, et al. Materials engineering strategies for cancer vaccine adjuvant development. Chem Soc Rev. 2023. 52(9): 2886-2910.

​​​

40. Yang L, Lang Y, Wu H, Xiang K, Wang Y, Yu M, Liu Y, Yang B, He L, Lu G, Ni Q*, et al. Engineered Toll-like receptor nanoagonist binding to extracellular matrix elicits safe and robust antitumor immunity. ACS Nano. 2023. 17(6): 5340-5353.

​​​

39. Xiang K, Wu H, Liu Y, Wang S, Li X, Yang B, Zhang Y, Ma L, Lu G, He L, Ni Q*, Zhang L. MOF-derived bimetallic nanozyme to catalyze ROS scavenging for protection of myocardial Iinjury. Theranostics. 2023. 13(8):2721-2733.

​​​

38. Wang Y, Yang Y, Yang L, Lin Y, Tian Y, Ni Q, Wang S, Ju H, Guo J, Lu G. Gold nanostar@polyaniline theranostic agent with high photothermal conversion efficiency for photoacoustic imaging-guided anticancer phototherapy at a low dosage. ACS Appl Mater Interfaces. 2022, 14(25):28570-28580.

​​​

37. Qiao H, Tang C, Schoepf UJ, Bayer RR, Tesche C, Jiang M, Yin C, Zhou C, Zhou F, Lu M, Jiang J, Lu G, Ni Q, Zhang L. One-year outcomes of CCTA alone versus machine learning-based FFRCT for coronary artery disease: a single-center, prospective study. Eur Radiol. 2022, 32(8):5179-5188.

​​​

36. Jiang M, Zhang XL, Liu H, Tang CX, Li JH, Wang YN, Xu PP, Zhou CS, Zhou F, Lu MJ, Zhang JY, Ni Q*, et al. The effect of coronary calcification on diagnostic performance of machine learning-based CT-FFR: A Chinese multicenter study. Eur Radiol. 2021. 3(31):1482-1493.

​​​

35. Zhang Y, Teng Z, Ni Q, Tao J, Cao X, Wen Y, Wu L, Fang C, Wan B, Zhang X, Lu G. Orderly curled silica nanosheets with a small size and macromolecular loading pores: synthesis and delivery of macromolecules to eradicate drug-resistant cancer. ACS Appl Mater Interfaces. 2020. 12(52):57810-57820.

​​​

34. Ni Q, Sun Z, Qi L, Chen W, Yang Y, Wang L, Zhang X, Yang L, Fang Y, Xing Z, Zhou Z, Yu Y, Lu G, Zhang L. A deep learning approach to characterize 2019 Coronavirus Disease (COVID-19) pneumonia in chest CT images. Eur Radiol. 2020.30(12):6517-6527.

​​​

33. Zhou Z, Deng H, Yang W, Wang Z, Lin L, Munasinghe J, Jacobson O, Liu Y, Tang L, Ni Q, Kang F, Liu Y, Niu G, Bai R, Qian C, Song J, Chen X. Early stratification of radiotherapy response by activatable inflammation magnetic resonance imaging. Nat Commun. 2020. 11(1):1-12.

​​​

32. Zu Z, Jiang M, Xu P, Chen W, Ni Q, Lu G, Zhang L. Coronavirus Disease 2019 (COVID-19): A perspective from China. Radiology. 2020. 296(2):E15-E25.

​​​

31. Xu P, Li JH, Zhou F, Jiang MD, Zhou CS, Lu MJ, Tang CX, Zhang XL, Yang L, Zhang YX, Wang YN, Ni Q*, et al. The influence of image quality on diagnostic performance of a machine learning based fractional flow reserve derived from coronary CT angiography. Eur Radiol. 2020. 30(5): 2525-2534.

​​​

30. He L, Ni Q, Mu J, Fan W, Liu L, Wang Z, Li L, Tang W, Liu Y, Cheng Y, Tang L, Yang Z, Liu Y, Zou J, Yang W, Jacobson O, Zhang F, Huang P, Chen X. Solvent-assisted self-assembly of a metal-organic framework based biocatalyst for cascade reaction driven photodynamic therapy. J Am Chem Soc. 2020. 142(14):6822-6832.

​​​

29. Wang X, Tian Y, Liao X, Tang Y, Ni Q, Sun J, Zhao Y, Zhang J, Teng Z, Lu G. Enhancing Selective Photosensitizer Accumulation and Oxygen Supply for High-efficacy Photodynamic Therapy Toward Glioma by 5-aminolevulinic Acid Loaded Nanoplatform. Biomaterials. 2020. 232:119677.

​​​​

28. Shi Z, Hu B, Schoepf UJ, Savage R, Dargis D, Pan C, Li X, Ni Q, Lu G, Zhang L. Artificial Intelligence in the Management of Intracranial Aneurysms: Current Status and Future Perspectives. AJNR Am J Neuroradiol. 2020. 41(3):373-379.

​​​

27. Zhua H, Cao X, Cai X, Tian Y, Wang D, Qi J, Teng Z, Lu G, Ni Q, Wang S, Zhang L. Pifithrin-μ in gold nanoparticle amplifies pro-apoptotic unfolded protein response cascades to potentiate synergistic glioblastoma therapy. Biomaterials. 2020. 232:119677.

​​​

26. Ni Q, Zhang F, Liu Y, Wang Z, Yu G, Liang B, Niu G, Su T, Zhu G, Lu G, Zhang L, Chen X. 2020. A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer. Sci Adv. 6(12): eaaw6071.

​​​

25. Ren Q, Yang K, Zou R, Wan Z, Shen Z, Wu G, Zhou Z, Ni Q, Fan W, Hu J, Liu Y. Biodegradable hollow manganese/cobalt oxide nanoparticles for tumor theranostics. Nanoscale. 2019. 11 (47), 23021-23026.

​​​

24. Zhou F, Tang C, Schoepf UJ, Tesche C, Rollins J, Liu H, Zhou C, Yan J, Lu M, Lu G, Ni Q, Zhang L. Machine learning using CT-FFR predicts proximal atherosclerotic plaque formation associated with LAD myocardial bridging. J Am Coll Cardiol Img. 2019. 12 (8), 1591-1593.

​​​​

23. Yu G, Cen TY, He Z, Wang SP, Wang Z, Ying XW, Li S, Jacobson O, Wang S, Wang L, Lin LS, Tian R, Zhou Z, Ni Q, Li X, Chen X. Porphyrin nanocage-embedded single-molecular nanoparticles for cancer nanotheranostics. Angew Chem Int Engl. 2019. 58(26):8799-8803.

​​​​

22. Yu Y, Ni Q, Wang Z, Chen M, Zhang L. Multiparametric functional magnetic resonance imaging for evaluating renal allograft injury. Korean J Radiol. 2019. 20(6):894-908.

​​​​

21. Ni Q, Pham NB, Meng WS, Zhu G, Chen X. Advances in immunotherapy of type I diabetes. Adv Drug Deliv Rev. 2019. 139:83-91.

​​​​

20. Zhang Y, Ni Q, Xu C, Wan B, Geng Y, Zheng G, Yang Z, Tao J, Zhao Y, Wen J, Zhang J, Wang S, Tang Y, Li Y, Zhang Q, Liu L, Teng Z, Lu G. Smart bacterial magnetic nanoparticles for tumor-targeting magnetic resonance imaging of Her2-positive breast cancers. ACS Appl Mater Interfaces. 2018. 11(4):3654-3665.

​​​​

19. Zhang F, Ni Q#, Jacobson O, Cheng S, Liao A, Wang Z, He Z, Yu G, Song J, Ma Y, Niu G, Zhang L, Zhu G, Chen X. Polymeric Nanoparticles with a glutathione-sensitive heterodimeric multifunctional prodrug for in vivo drug monitoring and synergistic cancer therapy. Angew Chem Int Engl. 2018. 57(24):7066-7070.

​​​​

18. Yang Z, Tian W, Wang Q, Zhao Y, Zhang Y, Tian Y, Tang Y, Wang S, Liu Y, Ni Q, Lu G, Teng Z, Zhang L. Oxygen‐evolving mesoporous organosilica coated prussian blue nanoplatform for highly efficient photodynamic therapy of tumorsdial bridging. Adv Sci. 2018. 5 (5), 1700847.

​​​​

17. Ni Q, Zhang F, Zhang Y, Zhu G, Wang Z, Teng Z, Wang C, Yung BC, Niu G, Lu G, Zhang L, Chen X. In situ shRNA synthesis on DNA–polylactide nanoparticles to treat multidrug resistant breast cancer. Adv Mater. 2018. 30(10): 1-10.

​​​​

16. Dai Y, Yang Z, Cheng S, Wang Z, Zhang R, Zhu G, Wang Z, Yung BC, Tian R, Jacobson O, Xu C, Ni Q, Song J, Sun X, Niu G, Chen X. Toxic reactive oxygen species enhanced synergistic combination therapy by self-assembled metal-phenolic network nanoparticles. Adv Mater. 2018. 30(8): 1-8.

​​​​

15. Dai Y, Cheng S, Wang Z, Zhang R, Yang Z, Wang J, Yung BC, Wang Z, Jacobson O, Xu C, Ni Q, Yu G, Zhou Z, Chen X. Hypochlorous Acid Promoted Platinum Drug Chemotherapy by Myeloperoxidase-encapsulated therapeutic metal phenolic nanoparticles. ACS Nano. 2018. 12(1):455-463.

​​​

14. Zhu G, Lynn GM, Jacobson O, Chen K, Liu Y, Zhang H, Ma Y, Zhang F, Tian R, Ni Q, Cheng S, Wang Z, Lu N, Yung BC, Wang Z, Lang L, Fu X, Jin A, Weiss ID, Vishwasrao H, Niu G, Shroff H, Klinman DM, Seder RA, Chen X. Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy. Nat Commun. 2017. 8(1):1-15.

​​​​

13. Chen W, Tian R, Xu C, Yung BC, Wang G, Liu Y, Ni Q, Zhang F, Zhou Z, Wang J, Niu G, Ma Y, Fu L, Chen X. Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy. Nat Commun. 2017. 8(1):11 pages.

​​​​

12. Zhang Y, Dang M, Tian Y, Zhu Y, Liu W, Tian W, Su Y, Ni Q, Xu C, Lu N, Tao J, Li Y, Zhao S, Zhao Y, Yang Z, Sun L, Teng Z, Lu G. Tumor Acidic Microenvironment Targeted Drug Delivery Based on pHLIP-modified Mesoporous Organosilica Nanoparticles. ACS Appl Mater Interfaces. 2017. 9(36):30543-30552.

​​​

11. Zhang F, Zhu G, Jacobson O, Liu Y, Chen K, Yu G, Ni Q, Fan J, Yang Z, Xu F, Fu X, Wang Z, Ma Y, Niu G, Zhao X, Chen X. Transformative nanomedicine of an amphiphilic camptothecin prodrug for long circulation and high tumor uptake in cancer therapy. ACS Nano. 2017. 11(9):8838-8848.

​​​​

10. Yang Z, Ni Q#, Schoepf UJ, De Cecco CN, Lin H, Duguay TM, Zhou C, Zhao Y, Lu G, Zhang L. Small intracranial aneurysms: diagnostic accuracy of CT angiography. Radiology. 2017. 285(3):941-952.

​​​​

9. Tian W, Su Y, Tian Y, Wang S, Su X, Liu Y, Zhang Y, Tang Y, Ni Q, Liu W, Dang M, Wang C, Zhang J, Teng Z, Lu G. Periodic mesoporous organosilica coated prussian blue for MR/PA dual‐Modal imaging‐guided photothermal‐chemotherapy of triple negative breast cancer. Adv Sci. 2017. 4(3):1600356.

​​​

8. Zhu G, Zhang F, Ni Q, Niu G, Chen X. Efficient nanovaccine delivery in cancer immunotherapy. ACS Nano. 2017. 11(3):2387-2392.

​​​

7. Dang M, Li W, Zheng Y, Su X, Ma X, Zhang Y, Ni Q, Tao J, Zhang J, Lu G, Teng Z, Wang L. Mesoporous organosilica nanoparticles with large radial pores via an assembly-reconstruction process in bi-phase. J Mater Chem B. 2017. 5(14):2625-2634.

​​

6. Ni Q, Teng Z, Dang M, Tian Y, Zhang Y, Huang P, Su X, Lu N, Yang Z, Tian W, Wang S, Liu W, Tang Y, Lu G, Zhang L. Gold nanorod embedded large-pore mesoporous organosilica nanospheres for gene and photothermal cooperative therapy of triple negative breast cancer. Nanoscale. 2016. 9(4):1466-1474.

​​​​

5. Fang X, Ni Q, Schoepf UJ, Zhou C, Chen G, Luo S, Fuller SR, De Cecco CN, Zhang L, Lu G. Image quality, radiation dose and diagnostic accuracy of 70 kVp whole brain volumetric CT perfusion imaging: a preliminary study. Eur Radiol. 2016. 26(11):4184-4193.

​​​

4. Ni Q, Chen G, Schoepf UJ, Klitsie MAJ, De Cecco CN, Zhou C, Luo S, Lu G, Zhang L. Cerebral CTA with low tube voltage and low contrast material volume for detection of intracranial aneurysms. AJNR Am J Neuroradiol. 2016. 37(10):1774-1780.

​​​​

3. Su Y, Teng Z, Yao H, Wang S, Tian Y, Zhang Y, Liu W, Tian W, Zheng L, Lu N, Ni Q, Su X, Tang Y, Sun J, Liu Y, Wu J, Yang G, Lu G, Zhang L. A multifunctional PB@mSiO2–PEG/DOX nanoplatform for combined photothermal–chemotherapy of tumor. ACS Appl Mater Interfaces. 2016. 8(27):17038-17046.

​​​​

2. Ni Q, Tang C, Zhao Y, Zhou C, Chen G, Lu G, Zhang L. Single phase dual-energy CT angiography: one-stop-shop tool for evaluating aneurysmal subarachnoid hemorrhage. Sci Rep. 2016. 6(1):26704.

​​​​

1. Li X, Ni Q, Schoepf UJ, Wichmann JL, Felmly LM, Qi L, Kong X, Zhou C, Luo S, Zhang L, Lu G. 70-kVp high-pitch computed tomography pulmonary angiography with 40 mL contrast agent: initial experience. Aca Radiol. 2015. 22(12):1562-1570.

​​​​